Notification of Allotment of Securities

Capital Change Notice




Section 1: Issuer information
Name of issuer Heartland Group Holdings
Limited
NZX ticker code HGH
Class of financial product Ordinary shares
ISIN (If unknown, check on NZX website) NZHGHE0007S9
Currency NZD
Section 2: Capital change details
Number issued/acquired/redeemed 4,790,946
Nominal value (if any) N/A
Issue/acquisition/redemption price per security $1.68653026
Nature of the payment (for example, cash or other
consideration)
Consideration satisfied
pursuant to the Dividend
Reinvestment Plan
Amount paid up (if not in full) Fully paid ordinary shares
Percentage of total class of Financial Products
issued/acquired/redeemed/ (calculated on the number of
Financial Products of the Class, excluding any Treasury Stock,
in existence)
1

0.67% of the total number of
fully paid ordinary shares prior
to this issue
For an issue of Convertible Financial Products or Options, the
principal terms of Conversion (for example the Conversion
price and Conversion date and the ranking of the Financial
Product in relation to other Classes of Financial Product) or the
Option (for example, the exercise price and exercise date)
N/A
Reason for issue/acquisition/redemption and specific authority
for issue/acquisition/redemption/ (the reason for change must
be identified here)
Issue of ordinary shares to
those shareholders that have
elected to participate in the
HGH Dividend Reinvestment
Plan, approved by directors’
resolutions.
Total number of Financial Products of the Class after the
issue/acquisition/redemption/Conversion (excluding Treasury
Stock) and the total number of Financial Products of the Class
held as Treasury Stock after the issue/acquisition/redemption.
715,724,340 ordinary shares
(excluding Treasury Stock)

459,070 Treasury Stock
In the case of an acquisition of shares, whether those shares
are to be held as treasury stock
N/A
Specific authority for the issue, acquisition, or redemption,
including a reference to the rule pursuant to which the issue,
acquisition, or redemption is made
Directors’ resolution
Issue of Ordinary Shares
under Listing Rule 4.8.1
Terms or details of the issue, acquisition, or redemption (for
example: restrictions, escrow arrangements)
Pursuant to the terms of the
HGH Dividend Reinvestment

1
The percentage is to be calculated immediately before the issue, acquisition, redemption or Conversion.

Plan Offer Document dated 10
December 2018
Date of issue/acquisition/redemption
2
20 September 2023
Section 3: Authority for this announcement and contact person
Name of person

authorised to make this announcement
Andrew Dixson, Chief
Financial Officer
Contact person for this announcement
Nicola Foley, Group Head of
Communications
Contact phone number 027 345 6809
Contact email address Nicola.Foley@heartland.co.nz
Date of release through MAP

21/09/2023




2
Continuous issuers using this form in reliance on Rule 3.13.2, please indicate the period during which the relevant
issue/acquisition/redemptions were made (for example, 1 January 2019 to 31 January 2019).